Benjamin F. Edwards & Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $67K | Buy |
+790
| New | +$67K | ﹤0.01% | 1252 |
|
|
2020
Q2 | – | Sell |
-212
| Closed | -$10K | – | 1740 |
|
|
2020
Q1 | $10K | Sell |
212
-413
| -66% | -$19.5K | ﹤0.01% | 1251 |
|
|
2019
Q4 | $41K | Sell |
625
-32
| -5% | -$2.1K | ﹤0.01% | 1019 |
|
|
2019
Q3 | $41K | Buy |
657
+622
| +1,777% | +$38.8K | ﹤0.01% | 990 |
|
|
2019
Q2 | $3K | Hold |
35
| – | – | ﹤0.01% | 1742 |
|
|
2019
Q1 | $3K | Buy |
+35
| New | +$3K | ﹤0.01% | 1567 |
|